A Phase 2a, Randomized, Double-Blind, Vehicle-Controlled Study, to Characterize the Mechanism of Action of
Crisaborole Ointment 2%, by Evaluation of Efficacy and Changes in Skin Biomarkers, in Adult Subjects With Mild to Moderate Atopic Dermatitis, With a 4 Week Open-Label Extension